This seminar series will be discussing issues of generalizability, transportability, and representation in Alzheimer’s disease (AD) diagnosis and clinical trials. We will be considering the role of AD biomarkers and other eligibility criteria in determining who enters the clinical trials and cohort studies on which we base our conclusions and clinical recommendations.
Keynote Lecturer of the 2026 Suzanne Labarge Lecture in Aging!
Congratulations to Dr. Caterina Rosano, Keynote Speaker at the 2026 Suzanne Labarge Lecture in Aging! We are thrilled to celebrate Dr. Caterina Rosano, who was selected as the keynote speaker for this year's Suzanne Labarge Lecture in Aging: Connecting Longevity with...








